Cost-effectiveness analysis of different dipeptidyl-peptidase 4 inhibitor drugs for treatment of type 2 diabetes mellitus.
Diabetes Metab Syndr
; 11 Suppl 2: S859-S865, 2017 Dec.
Article
in En
| MEDLINE
| ID: mdl-28701284
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Dipeptidyl-Peptidase IV Inhibitors
Type of study:
Health_economic_evaluation
Limits:
Humans
Language:
En
Journal:
Diabetes Metab Syndr
Year:
2017
Document type:
Article
Country of publication:
Netherlands